Home / Stocks / CLDI

CLDI insider trading

Calidi Biotherapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
4
Bought · 24 mo
$455k
Buys · last 90 days
0 · $0
Most recent buy
2025-08-25

Cluster buy detected

4 insiders bought CLDI within a short window (2025-08-21), $455k in total — cluster score 43/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-08-25Jackson Andrew C.cluster
Chief Financial Officer
Bought2,500$2.00$5k
2025-08-25Leftwich Scottcluster
Director
Bought125,000$2.00$250k
2025-08-25Poma Eric Ecluster
Chief Executive Officer
Bought25,000$2.00$50k
2025-08-25Schoeneck James Acluster
Director
Bought75,000$2.00$150k

Most active insider buyers

InsiderRoleBuysTotal bought
Leftwich ScottDirector1$250k
Schoeneck James ADirector1$150k
Poma Eric EChief Executive Officer1$50k
Jackson Andrew C.Chief Financial Officer1$5k

See CLDI on the chart

Every insider buy and sell for CLDI plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.